Tanke Biosciences Corporation (TNBI) — AI-Aktienanalyse

Tanke Biosciences Corporation develops, produces, and markets animal nutrition and feed additive products, primarily in China, Southeast Asia, and Latin America. The company operates through four segments: Organic Trace Mineral Additives, Functional Regulation Additives, Herbal Medicinal Additives, and Other.

Unternehmensueberblick

Kurzfassung:

Tanke Biosciences Corporation, operating within the financial services sector as a shell company, focuses on developing and marketing animal nutrition and feed additives. Its diverse product portfolio, including organic trace minerals and herbal medicinal additives, targets mid-to-large sized feed product factories and farmers across China, Southeast Asia, and Latin America.

Ueber TNBI

Founded in 1989 and headquartered in Guangzhou, China, Tanke Biosciences Corporation operates through its subsidiaries to develop, produce, and market animal nutrition and feed additive products. The company's operations are divided into four segments: Organic Trace Mineral Additives, Functional Regulation Additives, Herbal Medicinal Additives, and Other. Its product offerings include organic trace mineral additives under the Qili brand, feed acidifiers under the Qilicid name, flavor enhancers under the Tankeball name, and herbal medicinal additives under the Extra-Health, Qilimix, and Recoccider names. Tanke Biosciences also produces and markets trace mineral premix products for livestock and poultry under the Qilimix brand, as well as natural sweeteners and water-soluble organic multi-vitamin electrolytes. Tanke Biosciences serves mid-to-large sized feed product factories, large-scale feed producers, and farmers primarily in the People's Republic of China, Southeast Asia, and Latin America.

Investmentthese

Tanke Biosciences Corporation presents a challenging investment case given its status as an OTC-listed shell company operating in the animal nutrition and feed additive market. With a negative P/E ratio of -5.95 and a significantly negative profit margin of -2904.9%, the company's financial performance raises concerns. While the gross margin is relatively high at 76.8%, the lack of dividend and a negative beta of -0.79 further complicate the investment outlook. Growth catalysts would depend on successful expansion in its target markets and improved profitability, while potential risks include the inherent volatility and regulatory scrutiny associated with OTC-listed shell companies.

Branchenkontext

Tanke Biosciences operates within the animal nutrition and feed additive industry, a sector driven by the growing global demand for meat and dairy products. The industry is characterized by increasing focus on animal health, feed efficiency, and sustainable farming practices. Competitors range from large multinational corporations to smaller regional players. Tanke Biosciences focuses on serving mid-to-large sized feed product factories, large scale feed producers, and farmers primarily in the People's Republic of China, Southeast Asia, and Latin America.

Shell Companies

Financial Services

Wachstumschancen

Expansion in Southeast Asia: Tanke Biosciences can capitalize on the growing livestock and aquaculture industries in Southeast Asia. The region's increasing demand for meat and fish products drives the need for high-quality feed additives. By strengthening its distribution networks and tailoring products to local market needs, Tanke Biosciences can increase its market share in this region. This expansion could see revenue growth within the next 3-5 years, potentially increasing sales by 15-20%.
Product Diversification: Tanke Biosciences can expand its product line to include more specialized and value-added feed additives. This could include developing products that address specific animal health issues or improve feed efficiency. By offering a wider range of products, Tanke Biosciences can attract new customers and increase sales to existing customers. The timeline for this diversification is 2-3 years, with an expected revenue increase of 10-15%.
Strategic Partnerships: Tanke Biosciences can form strategic partnerships with feed product factories and large-scale feed producers. These partnerships can provide access to new markets and distribution channels. By collaborating with established players in the industry, Tanke Biosciences can accelerate its growth and increase its market reach. These partnerships could be established within the next year, leading to a 5-10% increase in market penetration.
Focus on Organic and Sustainable Products: Tanke Biosciences can focus on developing and marketing organic and sustainable feed additives. As consumers become more aware of the environmental impact of agriculture, there is a growing demand for organic and sustainable products. By offering these products, Tanke Biosciences can differentiate itself from its competitors and attract environmentally conscious customers. This focus could yield a 10-15% increase in sales within 3-4 years.
Investment in R&D: Tanke Biosciences should invest in research and development to create innovative and effective feed additives. This can help the company stay ahead of its competitors and meet the evolving needs of its customers. By developing new products and improving existing ones, Tanke Biosciences can maintain its competitive edge and drive long-term growth. A sustained R&D effort could lead to a 5-10% annual increase in product effectiveness and customer satisfaction.

Negative P/E ratio of -5.95, indicating the company is not currently profitable.
Gross margin of 76.8%, suggesting strong pricing power or efficient cost management in its product sales.
Negative profit margin of -2904.9%, highlighting significant challenges in achieving overall profitability.
Beta of -0.79, indicating the stock is less volatile than the market.
The company operates in four segments: Organic Trace Mineral Additives, Functional Regulation Additives, Herbal Medicinal Additives, and Other.

Was das Unternehmen tut

Develops organic trace mineral additives under the Qili brand.
Produces feed acidifiers used to prevent microbial degradation under the Qilicid name.
Offers seasonings and flavor enhancers used in blended feed production under the Tankeball name.
Creates herbal medicinal additives blended with feed products under the Extra-Health, Qilimix, and Recoccider names.
Produces and markets multiple trace mineral premix products for livestock and poultry under the Qilimix name.
Provides natural sweeteners and attractants for use with feed for pigs, piglets, fish, and other aquatic animals under the Tankeball name.
Offers water-soluble organic multi-vitamin electrolytes for animals.

Geschaeftsmodell

Develops and manufactures animal nutrition and feed additive products.
Markets and sells products directly to mid-to-large sized feed product factories, large scale feed producers, and farmers.
Generates revenue through product sales in the People's Republic of China, Southeast Asia, and Latin America.

Mid-to-large sized feed product factories
Large scale feed producers
Farmers in the People's Republic of China, Southeast Asia, and Latin America

Established brand names (Qili, Qilicid, Tankeball, Qilimix) in target markets.
Proprietary formulations for certain feed additive products.
Established relationships with key customers in target regions.

Katalysatoren

Ongoing: Expansion into new geographic markets, particularly in Southeast Asia, could drive revenue growth.
Ongoing: Development and launch of new, innovative feed additive products could attract new customers.
Ongoing: Strategic partnerships with feed producers and distributors could expand market reach.
Ongoing: Increasing demand for organic and sustainable feed additives could create new market opportunities.

Risiken

Potential: Intense competition from established players in the animal nutrition industry could limit market share.
Potential: Fluctuations in raw material prices could impact profitability.
Potential: Changes in government regulations related to animal feed and nutrition could increase compliance costs.
Potential: Economic downturns in key markets could reduce demand for the company's products.
Ongoing: The company's OTC listing and limited disclosure status pose significant risks to investors.

Staerken

Established presence in China, Southeast Asia, and Latin America.
Diverse product portfolio of animal nutrition and feed additives.
Proprietary formulations and established brand names.
Serves a wide range of customers, including feed product factories and farmers.

Schwaechen

Negative P/E ratio and profit margin, indicating financial instability.
Limited information available due to OTC listing and disclosure status.
Potential dependence on specific geographic markets.
Small market capitalization.

Chancen

Expansion into new geographic markets.
Development of new and innovative feed additive products.
Strategic partnerships with feed producers and distributors.
Growing demand for organic and sustainable feed additives.

Risiken

Intense competition from established players in the animal nutrition industry.
Fluctuations in raw material prices.
Changes in government regulations related to animal feed and nutrition.
Economic downturns in key markets.

Wettbewerber & Vergleichsunternehmen

Aiko Solar Energy Co Ltd — Focuses on solar energy, different industry. — (AIKO)
Carver Bancorp Inc — Community bank, different financial services niche. — (CRVH)
Infinite Acquisition Corp — Special purpose acquisition company (SPAC). — (IHAI)
Invesque Inc — Real estate investment trust (REIT) focused on healthcare properties. — (IVFZF)
Lichen China Limited — Unknown business model. — (LICH)

Key Metrics

Volume: 0
MoonshotScore: 58/100

Company Profile

CEO: Vincent W. Renz Jr.
Headquarters: Las Vegas, CN
Employees: 130
Founded: 2012

AI Insight

AI analysis pending for TNBI

OTC Tier: OTC Other
Disclosure Status: Unknown

Fragen & Antworten

What does Tanke Biosciences Corporation do?

Tanke Biosciences Corporation develops, produces, and markets a range of animal nutrition and feed additive products. These products include organic trace mineral additives, feed acidifiers, flavor enhancers, and herbal medicinal additives. The company serves mid-to-large sized feed product factories, large scale feed producers, and farmers primarily in the People's Republic of China, Southeast Asia, and Latin America, contributing to the animal feed supply chain in these regions.

What do analysts say about TNBI stock?

There is no available analyst coverage for TNBI stock, likely due to its OTC listing and status as a shell company. Key valuation metrics such as price targets and ratings are not available. Investors should conduct their own thorough due diligence and consider the risks associated with investing in OTC-listed companies with limited financial disclosure. The company's growth considerations would depend on its ability to improve profitability and expand its market reach.

What are the main risks for TNBI?

The main risks for TNBI include its OTC listing and limited disclosure status, which increase the potential for fraud and manipulation. The company's negative P/E ratio and profit margin indicate financial instability. Intense competition from established players in the animal nutrition industry, fluctuations in raw material prices, and changes in government regulations also pose significant risks. Investors should carefully consider these risks before investing in TNBI.

Is TNBI a good investment right now?

Use the AI score and analyst targets on this page to evaluate Tanke Biosciences Corporation (TNBI). Our analysis considers fundamentals, technicals, and market sentiment to help you decide.

What is the MoonshotScore for TNBI?

The MoonshotScore is a proprietary 0-100 AI rating that evaluates Tanke Biosciences Corporation across multiple dimensions including financial health, growth trajectory, and risk factors.

Where can I find TNBI financial statements?

Tanke Biosciences Corporation financial data including revenue, earnings, and balance sheet metrics are available in the Financials tab on this page, sourced from institutional-grade data providers.

What do analysts say about TNBI?

Analyst consensus targets and ratings for Tanke Biosciences Corporation are shown in the analysis section. These are aggregated from major Wall Street firms and updated regularly.

How volatile is TNBI stock?

Check the beta and historical price range on this page to assess Tanke Biosciences Corporation's volatility relative to the broader market.